Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Giovanni Caforio
Pharma
Novartis investor calls for board overhaul after costly setbacks
A top-20 Novartis investor urged Chairman Giovanni Caforio to increase the board's scrutiny of deals.
Angus Liu
Sep 10, 2026 10:26am
What are the noncompete considerations in Caforio's next move?
Jul 1, 2024 12:02pm
BMS paid Giovanni Caforio $19.7M in his final year as CEO
Mar 21, 2024 1:30pm
BMS has a plan to reinvigorate recent drug launches
Oct 26, 2023 11:45am
Securities filing details BMS' yearslong courtship of Mirati
Oct 24, 2023 11:41am
With Revlimid sales down, BMS slashes 2023 revenue projection
Jul 27, 2023 11:43am
